Igalmi

On heels of psych drug approval, BioXcel dives head first into oncology R&D with new cash infusion
Endpoints
Thu, 04/21/22 - 10:53 am
BioXcel
FDA
Igalmi
A Win for AI: FDA Approves BioXCel Therapy for Bipolar Disorder and Schizophrenia
BioSpace
Wed, 04/6/22 - 07:47 pm
BioXcel
artificial intelligence
bipolar disorder
schizophrenia
FDA
Igalmi